Factors associated with mortality of myxedema coma: report of eight cases and literature survey
Abstract
High-dose thyroid hormone replacement has been recommended for treatment of myxedema coma (MC) while questions of safety of the therapy and of efficacy of low-dose thyroid hormone replacement have not been systematically addressed. We treated 8 patients with MC in a period of 18 years, the first 3 with high-dose intravenous injections of levotriiodothyronine (LT3) and the other 5 patients with a smaller amount of either LT3 or levothyroxine (LT4). Two of the first 3 patients died of pneumonia and the other 5 recovered despite pulmonary abnormalities at the outset. To find factors associated with fatal outcome after treatment, the MEDLINE database was searched for MC cases with data of thyroid hormone replacement and outcome within 1 month of therapy. Clinical data for our 5 patients and 82 cases from the MEDLINE search were pooled and factors associated with mortality were sought among age, gender, presence of cardiac or pulmonary complications, and doses of thyroid hormone by multiple logistic regression analysis. It revealed that greater age, cardiac complications, and high-dose thyroid hormone replacement (LT4 > or = 500 microg/d or LT3 > or = 75 microg/d) were significantly associated with a fatal outcome within 1 month of treatment. Elderly MC patients can be treated with low-dose hormone replacement. A bolus of 500 microg LT4, especially by mouth or via nasogastric tube, appears to be tolerated by younger patients (< 55 years) without cardiac complication. The conclusion remains to be confirmed in more patients.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previous research has shown a positive correlation between the dose of IV LT4 and mortality in patients with myxedema.
“In addition, previous research has shown a positive correlation between the dose of IV LT4 and mortality in patients with myxedema (239).”
From Levothyroxine: conventional and novel drug delivery formulations. (2023) · cites this paper as [239]
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,333 · see citing works
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379 · see citing works
Burger, A., & Philippé, J. (1992) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80332-5 · Cited by 174 · see citing works
Treatment of Myxedema Coma With Intravenous Thyroxine
Holvey, D. N. (1964) · Archives of Internal Medicine · doi:10.1001/archinte.1964.00280070091015 · Cited by 123 · see citing works
Absorption of oral thyroxine in man
HAYS, M. T. (1968) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-28-6-749 · Cited by 111 · see citing works
Acute Metabolic Responses in Myxedema to Large Doses of Intravenous L -Thyroxine
Ridgway, E. C., McCammon, J. A., BENOTTI, J., & MALOOF, F. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-4-549 · Cited by 80 · see citing works
Arlot, S., Debussche, X., Lalau, J., et al. (1991) · Intensive Care Medicine · doi:10.1007/bf01708403 · Cited by 75 · see citing works
FORESTER, C. F. (1963) · Archives of Internal Medicine · doi:10.1001/archinte.1963.03620300054010 · Cited by 54 · see citing works
Myxedema coma during long-term amiodarone therapy
Mazonson, P. D., Williams, M. L., Cantley, L. K., Dalldorf, F. G., Utiger, R. D., & Foster, J. R. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90379-6 · Cited by 52 · see citing works
Pereira, V. G., Haron, E. S., Lima-Neto, N., & Medeiros-Neto, G. A. (1982) · Journal of Endocrinological Investigation · doi:10.1007/bf03350523 · Cited by 50 · see citing works
Myxedema coma associated with lithium therapy
Waldman, S. A., & Park, D. M. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80168-8 · Cited by 41 · see citing works
Nee, P. A., Scane, A. C., Lavelle, P. H., et al. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.6.1083 · Cited by 25 · see citing works
Delayed respiratory failure during the treatment of myxedema coma.
Yamamoto, T. (1984) · Endocrinologia Japonica · doi:10.1507/endocrj1954.31.769 · Cited by 18 · see citing works
Self-citationTriphasic Waves in Myxedema Coma
River, Y., & Zelig, O. (1993) · Clinical Electroencephalography · doi:10.1177/155005949302400313 · Cited by 17 · see citing works
Myxoedema coma presenting in status epilepticus
Woods, K., & Holmes, G. K. T. (1977) · Postgraduate Medical Journal · doi:10.1136/pgmj.53.615.46 · Cited by 17 · see citing works
[Myxedema coma as a rare postoperative complication].
Ragaller, M., Quintel, M., Hj, B., et al. (1993) · PubMed · Cited by 15 · see citing works
Cardiac enzyme changes in myxedema coma.
Hickman, P. E., Silvester, W., Musk, A. A., et al. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.4.622 · Cited by 15 · see citing works
Guidelines for the Treatment of Myxedema
Green, W. L. (1968) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)32935-2 · Cited by 14 · see citing works
Lindberger, K. (1975) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1975.tb19509.x · Cited by 9 · see citing works
The recognition and management of myxedema coma
Senior, R. M. (1971) · JAMA · doi:10.1001/jama.217.1.61 · Cited by 8 · see citing works
A Case of Myxoedema Coma Successfully Treated by Low Dose Oral Triiodothyronine
Graham, J. J., & Harding, P. E. (1977) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1977.tb04686.x · Cited by 5 · see citing works
A Survival Case of Myxedema Coma of Pituitary Origin
Murase, T., MUKOYAMA, A., Ohsawa, N., Nagataki, S., YAMAJI, T., & Tsushima, T. (1973) · Endocrinologia Japonica · doi:10.1507/endocrj1954.20.331 · Cited by 5 · see citing works
Desjars, P., Rostu, H. D., & Charbonnel, B. H. (1983) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(83)80028-9 · Cited by 5 · see citing works
Prolonged dystonic reaction to chlorpromazine in myxoedema coma
Wood, G., & Waters, A. K. (1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.653.192 · Cited by 4 · see citing works
Gilbert, R. E., Thomas, G., Hope, R. N., et al. (1992) · Anaesthesia and Intensive Care · doi:10.1177/0310057x9202000119 · Cited by 4 · see citing works
Is Myxedema Coma Respiratory Failure?
Nichols, A. B., & Hunt, W. B. (1976) · Southern Medical Journal · doi:10.1097/00007611-197607000-00048 · Cited by 4 · see citing works
Myxedema Coma and Normal Serum Thyroxine
LIZARRALDE, G., BALDWIN, J. G., McCULLEY, H. G., et al. (1978) · Southern Medical Journal · doi:10.1097/00007611-197807000-00033 · Cited by 3 · see citing works
Hyponatraemia complicating the treatment of myxoedema coma. A case report.
Berkowitz, I., & Bisceglie, D. (1986) · PubMed · Cited by 3 · see citing works
HAMBURGER, S. C., & Collier, R. E. (1982) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(82)80245-x · Cited by 3 · see citing works
High-dose thyroxine treatment of severe hypothyroidism: response of free thyroid hormones
Olbricht, T., Hoff, H.-G., & REINWEIN, D. (1985) · European Journal of Endocrinology · doi:10.1530/acta.0.109s082 · Cited by 2 · see citing works
Laubinger, G. (1974) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1107817 · Cited by 2 · see citing works
Cardiac arrest after intravenous administration of levothyroxine
Bacci, V. (1981) · JAMA · doi:10.1001/jama.245.9.920b · Cited by 2 · see citing works
Bertrand, Y., Roels, J., & Sondag, J. P. (1986) · Acta Clinica Belgica · doi:10.1080/22953337.1986.11719132 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928 · see citing works
“In the extreme case of myxedema coma, the literature clearly supports the use of TH replacement as the disease has a high mortality rate (595,599).”
InfluentialRoberts, C. G., & Ladenson, P. W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15696-1 · Cited by 567 · see citing works
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259 · see citing works
Wartofsky, L. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.003 · Cited by 158 · see citing works
Levothyroxine: conventional and novel drug delivery formulations.
Liu, H., Li, W., Zhang, W., Sun, S., & Chen, C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac030 · Cited by 63 · see citing works
van der Eerden, A. W., Twickler, M. T. B., Sweep, F. C. G. J., Beems, T., Hendricks, H. T., Hermus, A. R. M. M., & Vos, P. E. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0436 · Cited by 51 · see citing works
- Authors
- YAMAMOTO, T., FUKUYAMA, J., & FUJIYOSHI, A.
- Affiliations
- Kishiwada Tokushukai Hospital (JP)
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 1999-12
- Volume
- 9
- Issue
- 12
- Pages
- 1167-1174
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W2035545604
- Cited by
- 151
- References
- 33
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 7 · 2019: 14 · 2017: 13 · 2016: 6 · 2015: 3 · 2014: 7 · 2013: 7 · 2012: 8
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thyroid (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Medical Case Reports and Studies
- Keywords
- myxedema coma, mortality, thyroid hormone replacement, levothyroxine, cardiac complications, age, pneumonia
- MeSH terms
- Adult, Aged, Aged, 80 and over, Coma, Dose-Response Relationship, Drug, Female, Humans, Injections, Intravenous, Male, Middle Aged, Myxedema, Thyroxine, Triiodothyronine, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
